Neurohope Therapeutics, Inc.
Greenville, SC
- UEI
- YH1JEE27ME68
- CAGE
- 03W69
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 6 Monet Dr, Greenville, SC 29609, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $1,286,279 |
| FY2025 | $249,487 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $1,286,279 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Dexamethasone nanotherapeutics for traumatic brain injury | Defense Health Agency | $1,286,279 | |
| DHA sbir phase i for project titled, "dexamethasone nanotherapeutics for traumatic brain injury" | Defense Health Agency | $249,487 |
Quick answers
Is Neurohope Therapeutics, Inc. registered in SAM.gov?
Yes. Neurohope Therapeutics, Inc.'s SAM.gov registration is active through July 22, 2027.
How much has Neurohope Therapeutics, Inc. received in federal contracts?
Federal contracts obligated $249,487 to Neurohope Therapeutics, Inc. in fiscal year 2025 and $1,535,766 in fiscal years 2023 through 2027.
What is Neurohope Therapeutics, Inc.'s most recent federal award?
Neurohope Therapeutics, Inc.'s most recent federal contract award is Dexamethasone nanotherapeutics for traumatic brain injury (HT942726CE012), from Defense Health Agency, on April 6, 2026.
On GovTribe
See Neurohope Therapeutics, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors